New Zealand markets open in 8 hours 38 minutes

ICON Public Limited Company (ICLR)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
213.07-5.62 (-2.57%)
At close: 04:00PM EST
210.00 -3.07 (-1.44%)
Pre-market: 07:10AM EST

ICON Public Limited Company

South County Business Park
Dublin 18
353 1 291 2000

IndustryDiagnostics & Research
Full-time employees41,150

Key executives

NameTitlePayExercisedYear born
Dr. Steven A. Cutler MBA, Ph.D.CEO & Director3.64MN/A1960
Mr. Brendan BrennanChief Financial Officer1.63MN/A1979
Jonathan CurtainSr. VP of Corp. & Commercial Fin.N/AN/AN/A
Mr. Thomas N. O'LearyChief Information OfficerN/AN/AN/A
Mr. Diarmaid CunninghamChief Admin. Officer, Gen. Counsel, Exec. VP & Company Sec.N/AN/A1975
Ms. Niamh MurphyDirector of Corp. CommunicationsN/AN/AN/A
Mr. David GreenVP of MarketingN/AN/AN/A
Mr. Joe CroninChief HR OfficerN/AN/AN/A
Mr. Simon HolmesPres of Corp. Investments & PartnershipsN/AN/A1967
Ms. Dana Lynn Poff Snr.Exec. VP of Program ManagementN/AN/AN/A
Amounts are as of 31 December 2021, and compensation values are for the last fiscal year ending on that date. Pay includes salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.


ICON Public Limited Company, a clinical research organization, provides outsourced development and commercialization services in Ireland, rest of Europe, the United States, and internationally. The company specializes in the strategic development, management, and analysis of programs that support various stages of the clinical development process from compound selection to Phase I-IV clinical studies. It offers clinical development services, including early development, patient recruitment and retention, strategy and analytics, late phase research, data and technology solution, and consulting and analytics services. The company's clinical development services also comprise medical imaging, clinical research and laboratory services, project management, site monitoring and management services, data management, biostatistics and programming, medical writing and publishing, medical affair, endpoint adjudication/data monitoring committees, pharmacovigilance, interactive response technologies, clinical supplies management, strategic regulatory, medical communication, and consulting and advisory services. It serves pharmaceutical, biotechnology, and medical device industries, as well as government and public health organizations. The company was incorporated in 1990 and is headquartered in Dublin, Ireland.

Corporate governance

ICON Public Limited Company’s ISS governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder rights: N/A; Compensation: N/A.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while 10 indicates higher governance risk.